SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 32 filers reported holding SINOVAC BIOTECH LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $76,000 | -81.4% | 10,195 | -82.4% | 0.00% | -100.0% |
| Q3 2017 | $409,000 | -7.5% | 58,083 | -11.3% | 0.00% | 0.0% |
| Q2 2017 | $442,000 | +38.1% | 65,447 | +17.2% | 0.00% | 0.0% |
| Q1 2017 | $320,000 | +290.2% | 55,852 | +287.9% | 0.00% | – |
| Q4 2015 | $82,000 | -43.4% | 14,400 | -49.5% | 0.00% | – |
| Q3 2015 | $145,000 | -12.7% | 28,500 | -10.1% | 0.00% | – |
| Q4 2014 | $166,000 | -16.6% | 31,700 | -23.4% | 0.00% | -100.0% |
| Q3 2014 | $199,000 | -57.9% | 41,408 | -50.7% | 0.00% | 0.0% |
| Q2 2014 | $473,000 | -38.6% | 83,934 | -21.5% | 0.00% | -50.0% |
| Q1 2014 | $770,000 | +335.0% | 106,953 | +262.1% | 0.00% | +100.0% |
| Q3 2013 | $177,000 | +60.9% | 29,539 | +5.5% | 0.00% | – |
| Q2 2013 | $110,000 | – | 27,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
| Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
| Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
| FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
| FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
| Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
| ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |